Nutex Health Inc. (NUTX)

NCM – Real vaqt narxi. Valyuta: USD

172.46

+6.01 (3.61%)

Yopilishda: Aug 12, 2026, 3:59 PM EDT

172.70

+0.25 (0.14%)

Bozordan keyin: Aug 12, 2026, 4:16 PM EDT

12.08.2026

Nutex Health: A 'Strong Buy' Amid Margin Expansion, Regulatory Tailwinds (Upgrade)

Nutex Health upgraded to "Strong Buy" as margin expansion and patient volume growth drive bullish outlook. Despite a 13% YoY revenue decline, Q2 saw 9.6% patient volume growth and significant, sustainable operating cost reductions. CMS administrative fee cuts and the HaloMD contract amendment are expected to lower normalized costs by 25%–30% in future periods.

08.08.2026

Nutex Health Inc. (NUTX) Q2 2026 Earnings Call Transcript

07.08.2026

Nutex Health Q2 Earnings Call Highlights

Nutex Health NASDAQ: NUTX reported higher second-quarter profitability and adjusted EBITDA despite lower revenue, as the company benefited from reduced arbitration-related costs, lower stock-based compensation and continued patient-volume growth.

06.08.2026

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

HOUSTON, Aug. 6, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today announced financial results for the three and six months ended June 30, 2026. Nutex Health is a physician-led, healthcare services and operations company with 27 hospital facilities in 12 states (hospital division), and a primary care-centric, risk-bearing physician network.

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

Nutex Health Inc. (NUTX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Nutex Health Inc. (NUTX)

Nutex Health: A 'Strong Buy' Amid Margin Expansion, Regulatory Tailwinds (Upgrade)

Nutex Health Inc. (NUTX) Q2 2026 Earnings Call Transcript

Nutex Health Q2 Earnings Call Highlights

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Videolar

No Data

Press-relizlar

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Nutex Health: A 'Strong Buy' Amid Margin Expansion, Regulatory Tailwinds (Upgrade)

Nutex Health Inc. (NUTX) Q2 2026 Earnings Call Transcript

Nutex Health Q2 Earnings Call Highlights

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Videolar

No Data

Press-relizlar

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Search stocks

Nutex Health Inc. (NUTX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Nutex Health Inc. (NUTX)

Nutex Health: A 'Strong Buy' Amid Margin Expansion, Regulatory Tailwinds (Upgrade)

Nutex Health Inc. (NUTX) Q2 2026 Earnings Call Transcript

Nutex Health Q2 Earnings Call Highlights

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Videolar

No Data

Press-relizlar

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Nutex Health: A 'Strong Buy' Amid Margin Expansion, Regulatory Tailwinds (Upgrade)

Nutex Health Inc. (NUTX) Q2 2026 Earnings Call Transcript

Nutex Health Q2 Earnings Call Highlights

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Videolar

No Data

Press-relizlar

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS